Summary
Background Preterm birth, defined as birth occurring before 37 weeks of gestation, poses a significant and enduring public health challenge, with substantial emotional and financial burdens on families and society. To identify preterm births early in pregnancy, we investigated the predictive ability of machine learning models in a nulliparous (first-time pregnancy) study cohort. Preterm births are categorized into two major types: indicated preterm birth, which occurs due to medical conditions such as preeclampsia or other maternal/fetal complications requiring early delivery, and spontaneous preterm birth, which involves the natural onset of preterm labor. Our research aims to develop predictive tools that could enable earlier intervention and improved outcomes for these vulnerable pregnancies.
Methods Our study analyzed the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be cohort (nu-MoM2b), comprising data from eight clinical sites throughout the United States from October 2010 to May 2014, including treatment, psychological, physiological, medical history, demographic, ultrasound, activity, toxicology, family history, pre-pregnancy diet, and genetic race. We distinguished between spontaneous and indicated preterm births to develop targeted predictive models for each subtype. We also used a novel approach to predict preterm birth called learning with privileged information, information available during training but often inaccessible during evaluation. Specifically, the set of privileged information that we utilized for PTB prediction includes the occurrence of adverse pregnancy outcomes (APOs), after-delivery physiology information, and maternal outcomes. We developed an enhanced model, XGBoost+, which incorporates this privileged information to improve predictive performance compared to traditional machine learning approaches.
Results We selected XGBoost as our base model due to its robust performance with tabular data and its ensemble approach that effectively mitigates overfitting while capturing complex relationships between clinical variables, making it particularly well-suited for the heterogeneous risk factors associated with preterm birth prediction. XGboost-based models achieved higher AUC against all other models, including decision tree, random forest, logistic regression, and SVM for all visits. Our XGboost+ model, utilizing privileged information, achieved an AUC of 0.72. Analyzing the subcategories of preterm birth, XGboost+ achieved similar performance with XGboost for spontaneous preterm birth (0.68 AUC versus 0.67 AUC), but improvements were more significant for indicated preterm birth (0.78 versus 0.74). These results demonstrate the benefits of how information that is not typically utilized in traditional machine learning models can help build better models.
Conclusion Our extensive analysis of this comprehensive set of risk factors revealed preterm birth as a multifaceted issue, with different risk factors associated with two subcategories of preterm birth - spontaneous and indicated. No-tably, we achieved significant success in predicting indicated preterm birth, demonstrating strong predictive performance (AUC 0.78) using our XGBoost+ model. This finding represents an important advancement, as indicated preterm birth is influenced mainly by conditions related to hypertension and preeclampsia, which our model effectively captured. While spontaneous preterm birth remains challenging to predict with clinical data alone, especially in early pregnancy, our research successfully differentiates between these subtypes and provides a valuable predictive tool for indicated preterm birth. The complexity of spontaneous preterm birth suggests that future research should focus on gathering more proximal biological data, including vaginal microbiota or raw cervical images, to complement our successful approach for indicated preterm birth prediction.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by grant funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) grant number R01LM013327. The funder played no role in study design, data collection, analysis and interpretation of data, or the writing of this manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study, titled “SCH: Prediction of Preterm Birth in Nulliparous Women,” was conducted with full ethical oversight and approval. The research protocol underwent comprehensive review and received approval from both the Columbia University Human Subjects Institutional Review Board and the City University of New York (CUNY) Institutional Review Board. All research activities were performed in accordance with relevant guidelines and regulations for human subjects research. Informed consent was obtained from all participants prior to their inclusion in the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced are available online at NICHD Dash: Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be (nuMoM2b)
Data Availability
The datasets generated and analyzed during the current study were obtained from the NIH Data and Specimen Hub (DASH). Access restrictions apply to these data in accordance with data use agreements and participant privacy protections. While the raw data are not publicly available due to these restrictions, researchers may request access through formal application to the NIH DASH repository. Qualified researchers can obtain the data by submitting a request to the repository administrators and securing appropriate institutional permissions. The authors will facilitate data access requests when possible, subject to compliance with all applicable regulations and the original data use agreement terms.





